Companies Cryptocurrencies
Scholar Rock Holding Corp
Scholar Rock Holding Corp
Exchange: NasdaqGS
IPO Date: 24/05/2018
CEO: Dr. Nagesh Mahanthappa
Biotechnology Healthcare 🔗
  • SRRK
  • 5.01
  • 176861520
    market cap
  • -0.08999968
If you bought

shares of Scholar Rock Holding Corp (SRRK) on
You would have made
Old Price $12 Current Price $12

Scholar Rock Holding Corp. is a biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 69 full-time employees. The firm is engaged in the development of monoclonal antibodies for treatment of diseases, such as neuromuscular disorders, cancer, fibrosis, and anemia. The firm’s lead product candidate is SRK-015 that is in its pre-clinical stage of development. SRK-015 is a selective inhibitor of the activation of the growth factor myostatin in skeletal muscle. The company is used to treat spinal muscular atrophy (SMA). The firm also develops other antibody programs that include TGF?1 and BMP6. The TGF?1 antibody program is focused on the development of antibodies that are specific inhibitors of TGF?1 members.

Address: 620 Memorial Dr Fl 2 Cambridge MASSACHUSETTS 02139

Stay updated.